サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1376454

商業用バイオテクノロジー分離システム市場：方法、用途別-2023-2030年の世界予測

Commercial Biotechnology Separation Systems Market by Method (Conventional Methods, Modern Methods), Application (Agriculture, Biopharmaceutical, Cosmetics & Personal Care) - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
商業用バイオテクノロジー分離システム市場：方法、用途別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

商業用バイオテクノロジー分離システム市場は、2022年の238億4,000万米ドルから2030年には592億4,000万米ドルに達すると予測され、予測期間中のCAGRは12.04%です。

商業用バイオテクノロジー分離システムの世界市場

主な市場の統計
市場金額：基準年[2022] 238億4,000万米ドル
推定市場金額[2023] 265億5,000万米ドル
予測市場金額[2030] 592億4,000万米ドル
CAGR（%） 12.04%
商業用バイオテクノロジー分離システム Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは商業用バイオテクノロジー分離システム市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.商業用バイオテクノロジー分離システム市場の市場規模および予測は？

2.商業用バイオテクノロジー分離システム市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.商業用バイオテクノロジー分離システム市場における競争戦略の窓とは？

4.商業用バイオテクノロジー分離システム市場の最新技術動向と規制の枠組みは？

5.商業用バイオテクノロジー分離システム市場における主要ベンダーの市場シェアは？

6.商業用バイオテクノロジー分離システム市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 個別化医療と細胞ベースの治療に対する需要の増大
      • 政府による研究開発資金の増加
      • プラスチックや化学品の商業生産における磁気選別機の採用拡大
    • 抑制要因
      • 商業用バイオテクノロジー分離システムに関連する高コスト
    • 機会
      • 商業用バイオテクノロジー分離システムの継続的な進歩
      • 政府は中小企業に新しい技術を導入するための資金援助を行っています
    • 課題
      • 製品の品質に関する厳しい規制要件に関する問題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 商業用バイオテクノロジー分離システム市場：方法別

  • 従来の方法
    • 遠心分離
    • クロマトグラフィー
    • 電気泳動
    • フローサイトメトリー
    • 膜ろ過
  • 現代の手法
    • バイオチップ
    • ラボオンチップ
    • 磁気分離
    • マイクロアレイ

第7章 商業用バイオテクノロジー分離システム市場：用途別

  • 農業
  • バイオ医薬品
  • 化粧品とパーソナルケア
  • 飲食品

第8章 南北アメリカの商業用バイオテクノロジー分離システム市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の商業用バイオテクノロジー分離システム市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの商業用バイオテクノロジー分離システム市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Agilent Technologies, Inc.
    • Alfa Laval AB
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Danaher Corporation
    • GE HealthCare Technologies Inc.
    • GL Sciences Inc.
    • Hitachi, Ltd.
    • Illumina, Inc.
    • JASCO International Co., Ltd.
    • LECO Corporation
    • Luminex Corporation by DiaSorin S.p.A.
    • Merck KGaA
    • Miltenyi Biotec B.V. & Co. KG
    • Novasep Holding SAS
    • PerkinElmer Inc.
    • QIAGEN N.V.
    • Repligen Corporation
    • Sartorius AG
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Tosoh Corporation
    • Waters Corporation
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET DYNAMICS
  • FIGURE 7. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
  • FIGURE 8. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 10. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 12. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 14. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 20. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 6. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 8. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 15. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOCHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 193. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 194. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET LICENSE & PRICING
目次
Product Code: MRR-521BAA36EAA1

The Commercial Biotechnology Separation Systems Market is projected to reach USD 59.24 billion by 2030 from USD 23.84 billion in 2022, at a CAGR of 12.04% during the forecast period.

Global Commercial Biotechnology Separation Systems Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 23.84 billion
Estimated Year Value [2023] USD 26.55 billion
Forecast Year Value [2030] USD 59.24 billion
CAGR (%) 12.04%
Commercial Biotechnology Separation Systems Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Commercial Biotechnology Separation Systems Market.

Based on Method, market is studied across Conventional Methods and Modern Methods. The Conventional Methods is further studied across Centrifugation, Chromatography, Electrophoresis, Flow cytometry, and Membrane filtration. The Modern Methods is further studied across Biochip, Lab-on-a-chip, Magnetic separation, and Microarray. The Modern Methods is projected to witness significant market share during forecast period.

Based on Application, market is studied across Agriculture, Biopharmaceutical, Cosmetics & Personal Care, and Food & Beverage. The Food & Beverage is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Commercial Biotechnology Separation Systems Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Commercial Biotechnology Separation Systems Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Commercial Biotechnology Separation Systems Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, GE HealthCare Technologies Inc., GL Sciences Inc., Hitachi, Ltd., Illumina, Inc., JASCO International Co., Ltd., LECO Corporation, Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novasep Holding SAS, PerkinElmer Inc., QIAGEN N.V., Repligen Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, and Waters Corporation.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Commercial Biotechnology Separation Systems Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Commercial Biotechnology Separation Systems Market?

3. What is the competitive strategic window for identifying opportunities in the Commercial Biotechnology Separation Systems Market?

4. What are the latest technology trends and regulatory frameworks in the Commercial Biotechnology Separation Systems Market?

5. What is the market share of the leading vendors in the Commercial Biotechnology Separation Systems Market?

6. Which modes and strategic moves are suitable for entering the Commercial Biotechnology Separation Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Commercial Biotechnology Separation Systems Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for personalized medicines and cell-based therapies
      • 5.1.1.2. Rise in funding by the government for research and development
      • 5.1.1.3. Expanding adoption of magnetic separators for commercial production of plastics and chemicals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with commercial biotechnology separation systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in commercial biotechnology separation systems
      • 5.1.3.2. Government provides financial assistance to SMEs to introduce novel technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Problems regarding stringent regulation requirements for product quality
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Commercial Biotechnology Separation Systems Market, by Method

  • 6.1. Introduction
  • 6.2. Conventional Methods
    • 6.3.1. Centrifugation
    • 6.3.2. Chromatography
    • 6.3.3. Electrophoresis
    • 6.3.4. Flow cytometry
    • 6.3.5. Membrane filtration
  • 6.3. Modern Methods
    • 6.4.1. Biochip
    • 6.4.2. Lab-on-a-chip
    • 6.4.3. Magnetic separation
    • 6.4.4. Microarray

7. Commercial Biotechnology Separation Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Agriculture
  • 7.3. Biopharmaceutical
  • 7.4. Cosmetics & Personal Care
  • 7.5. Food & Beverage

8. Americas Commercial Biotechnology Separation Systems Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Commercial Biotechnology Separation Systems Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Commercial Biotechnology Separation Systems Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Agilent Technologies, Inc.
    • 12.1.2. Alfa Laval AB
    • 12.1.3. Becton, Dickinson and Company
    • 12.1.4. Bio-Rad Laboratories, Inc.
    • 12.1.5. bioMerieux SA
    • 12.1.6. Danaher Corporation
    • 12.1.7. GE HealthCare Technologies Inc.
    • 12.1.8. GL Sciences Inc.
    • 12.1.9. Hitachi, Ltd.
    • 12.1.10. Illumina, Inc.
    • 12.1.11. JASCO International Co., Ltd.
    • 12.1.12. LECO Corporation
    • 12.1.13. Luminex Corporation by DiaSorin S.p.A.
    • 12.1.14. Merck KGaA
    • 12.1.15. Miltenyi Biotec B.V. & Co. KG
    • 12.1.16. Novasep Holding SAS
    • 12.1.17. PerkinElmer Inc.
    • 12.1.18. QIAGEN N.V.
    • 12.1.19. Repligen Corporation
    • 12.1.20. Sartorius AG
    • 12.1.21. Shimadzu Corporation
    • 12.1.22. Thermo Fisher Scientific Inc.
    • 12.1.23. Tosoh Corporation
    • 12.1.24. Waters Corporation
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing